IPO registrations (S-1, F-1) · Registrants
Spark Therapeutics, Inc.
- SEC CIK
- 1609351 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2014-12-30, last 2015-12-14; 2 initial registrations, 3 amendments
- Outcome
- Final prospectus filed 2015-01-30; declared effective 2015-01-29
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Incorporated in
- DE
- Business address
- 3737 MARKET STREET, SUITE 1300, Philadelphia, PA 19104
- EIN
- 46-2654405
- EDGAR entity type
- operating
- Insiders and CEO pay
- Spark Therapeutics, Inc. on the corporate pages
Offering terms
- Proposed price range
- $19.00–$21.00 per share (S-1/A filed 2015-01-28)
- Final price
- $23.00 per share, above the range (424B4 filed 2015-01-30, an initial public offering)
- Shares sold
- 7,000,000
- Gross proceeds
- $161,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol ONCE
- Lead underwriters
- J.P. Morgan; Credit Suisse
- Syndicate
- Cowen; Sanford C. Bernstein
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: Spark Therapeutics, Inc. Fuzzy (name and state)
- Business registration: SPARK THERAPEUTICS, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: SPARK THERAPEUTICS, INC. EXACT (EIN (EXACT))
- Political committee (FEC): SPARK THERAPEUTICS, INC. PAC (SPARK PAC) (connected to SPARK THERAPEUTICS, INC.) Fuzzy (name and state)
- Federal award recipient: SPARK THERAPEUTICS, INC. Fuzzy (name and state)
- Form D issuer: Spark Therapeutics, Inc. EXACT (CIK (EXACT))
- Lobbying client: SPARK THERAPEUTICS Fuzzy (name and state)
- Lobbying client: SPARK THERAPEUTICS, INC. Fuzzy (name and state)
- Lobbying client: SPARK THERAPEUTICS, INC. Fuzzy (name and state)
- Lobbying client: SPARK THERAPEUTICS, INC. Fuzzy (name and state)
- Lobbying client: SPARK THERAPEUTICS, INC. Fuzzy (name and state)
- Lobbying registrant: SPARK THERAPEUTICS, INC. Fuzzy (name and state)
- SEC filer: Spark Therapeutics, Inc. EXACT (CIK (EXACT))
- Person page: Katherine A High Md Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer))
Filings 11
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2014-12-30 | S-1 | S-1 (registration) | Spark Therapeutics, Inc. | 0001193125-14-457223 ↗ |
| 2015-01-20 | S-1/A | S-1/A (amendment) | Spark Therapeutics, Inc. | 0001193125-15-013888 ↗ |
| 2015-01-28 | S-1/A | S-1/A (amendment) | Spark Therapeutics, Inc. | 0001193125-15-022513 ↗ |
| 2015-01-29 | S-1MEF | S-1MEF (added securities) | Spark Therapeutics, Inc. | 0001193125-15-026236 ↗ |
| 2015-01-29 | EFFECT | EFFECT (declared effective) | Spark Therapeutics, Inc. | 9999999995-15-000250 ↗ |
| 2015-01-30 | 424B4 | 424B4 (final prospectus) | Spark Therapeutics, Inc. | 0001193125-15-026535 ↗ |
| 2015-11-25 | S-1 | S-1 (registration) | Spark Therapeutics, Inc. | 0001193125-15-388870 ↗ |
| 2015-12-14 | S-1/A | S-1/A (amendment) | Spark Therapeutics, Inc. | 0001193125-15-402568 ↗ |
| 2015-12-15 | EFFECT | EFFECT (declared effective) | Spark Therapeutics, Inc. | 9999999995-15-003293 ↗ |
| 2015-12-16 | 424B1 | 424B1 (final prospectus) | Spark Therapeutics, Inc. | 0001193125-15-404834 ↗ |
| 2016-06-22 | EFFECT | EFFECT (declared effective) | Spark Therapeutics, Inc. | 9999999995-16-004976 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2015-01-28 | S-1/A | registration statement | $19.00–$21.00 | 6,500,000 | - | Nasdaq ONCE | 4 | primary document; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 4 | document ↗ | |
| 2015-01-30 | 424B4 | final prospectus | $23.00 | 7,000,000 | $161,000,000 | Nasdaq ONCE | 4 | primary document; price sentence, shares headline, proceeds table, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| AKKARAJU SRINIVAS | TenPercentOwner | 1 | 2015 | ||
| Altschuler Steven | Director; Director,TenPercentOwner | 8 | 2015–2019 | ||
| Betz Alert Lorris | Director | 4 | 2015–2017 | ||
| Children's Hospital of Philadelphia Foundation | Director,TenPercentOwner; TenPercentOwner | 11 | 2015–2019 | ||
| Ekman Lars | Director | 6 | 2015–2019 | ||
| HEALY JAMES | TenPercentOwner | 1 | 2015 | ||
| High Katherine A | Director,Officer | See Remarks | 30 | 2015–2019 | person page Fuzzy |
| Marrazzo Jeffrey D | Director,Officer | Chief Executive Officer; CHIEF EXECUTIVE OFFICER | 29 | 2015–2019 | |
| Mehra Anand | Director; Director,TenPercentOwner | 26 | 2015–2019 | ||
| MILANO VINCENT | Director | 6 | 2015–2019 | ||
| POWELL MICHAEL | TenPercentOwner | 1 | 2015 | ||
| SIGAL ELLIOT | Director | 8 | 2015–2019 | ||
| Sofinnova Management VIII, L.L.C. | TenPercentOwner | 1 | 2015 | ||
| Sofinnova Venture Partners VIII, L.P. | TenPercentOwner | 1 | 2015 | ||
| Vivaldi Coelho Rogerio | Officer | Chief Commercial Officer | 7 | 2015–2016 | |
| Webster Stephen W | Officer | Chief Financial Officer; CHIEF FINANCIAL OFFICER | 16 | 2015–2019 | |
| Zoth Lota S. | Director; Director,Officer | CHIEF SCIENTIFIC OFFICER | 7 | 2016–2019 | |
| Faga Daniel | Officer | Chief Business Officer | 15 | 2016–2019 | |
| La Barge Joseph | Officer | Chief Legal Officer; CHIEF LEGAL OFFICER; General Counsel; See remarks | 18 | 2016–2019 | |
| Furey John | Officer | Chief Operating Officer | 7 | 2016–2018 | |
| PEREZ ROBERT J | Director | 6 | 2018–2019 | ||
| Dalton Lisa | Officer | Chief Human Resource Officer; CHIEF HUMAN RESOURCE OFFICER; Head of Human Resources | 4 | 2018–2019 | |
| Mingozzi Federico | Officer | Chief Scientific Officer; CHIEF SCIENTIFIC OFFICER | 5 | 2018–2019 | |
| ROCHE HOLDING LTD | TenPercentOwner | 1 | 2019 | ||
| ROCHE HOLDINGS INC | TenPercentOwner | 1 | 2019 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2014-06-06 | Spark Therapeutics, Inc. | Biotechnology | $72,800,000 | $72,800,000 | 28 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | Spark Therapeutics, Inc. | PA | State business registries | name and state |
| Business registration | SPARK THERAPEUTICS, INC. | PA | State business registries | name and state |
| Plan sponsor | SPARK THERAPEUTICS, INC. | PA | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Political committee | SPARK THERAPEUTICS, INC. PAC (SPARK PAC) (connected to SPARK THERAPEUTICS, INC.) | PA | Campaign finance (FEC) | name and state |
| Federal award recipient | SPARK THERAPEUTICS, INC. | PA | Federal spending (USAspending) | name and state |
| Form D issuer | Spark Therapeutics, Inc. | PA | Form D private offerings | CIK (EXACT) |
| Lobbying client | SPARK THERAPEUTICS | PA | Federal lobbying (LDA) | name and state |
| Lobbying client | SPARK THERAPEUTICS, INC. | PA | Federal lobbying (LDA) | name and state |
| Lobbying client | SPARK THERAPEUTICS, INC. | PA | Federal lobbying (LDA) | name and state |
| Lobbying client | SPARK THERAPEUTICS, INC. | PA | Federal lobbying (LDA) | name and state |
| Lobbying client | SPARK THERAPEUTICS, INC. | PA | Federal lobbying (LDA) | name and state |
| Lobbying registrant | SPARK THERAPEUTICS, INC. | PA | Federal lobbying (LDA) | name and state |
| Paying company | Spark Therapeutics, Inc. | PA | Open Payments (drug and device company payments) | name and state |
| Patent assignee | SPARK THERAPEUTICS, INC. | PA | Patents (USPTO) | name and state |
| SEC filer | Spark Therapeutics, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Spark Therapeutics, Inc. | PA | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | SPARK THERAPEUTICS, INC. | EIN (EXACT) | ||
| Person page | Katherine A High Md | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), PA first:
- APOLLON INC PA
- Aevi Genomic Medicine, LLC PA
- Ocugen, Inc. PA
- Krystal Biotech, Inc. PA
- Cabaletta Bio, Inc. PA
- Passage BIO, Inc. PA
- Century Therapeutics, Inc. PA
- Aphton CORP PA
- Aceragen, Inc. PA
- GENAERA CORP PA
In other datasets, the same topic (Health) in PA:
- Nonprofit: 445 FOUNDATION (Nonprofits (IRS Form 990))
Interests: Biological Products, (No Diagnostic Substances) · Health